Restasis Multidose Emulsion
Product Images NDC 0023-5301

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Restasis Multidose (NDC 0023-5301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Restasis Multidose 01

An instructional illustration showing a close-up of a hand holding an ophthalmic emulsion bottle. The image depicts the bottle's cap with arrows indicating the direction to twist or remove it. This is consistent with instructions for preparing or opening Restasis MultiDose emulsion, cyclosporine 0.5 mg/mL, by Allergan, Inc.*

FDA Label Image

Restasis Multidose 02

An instructional illustration showing how to remove a pull tab from the cap of a Restasis MultiDose ophthalmic emulsion bottle. A close-up inset highlights the detail of the pull tab on the cap. The image demonstrates the initial step of opening the medication bottle.*

FDA Label Image

Restasis Multidose 03

Instructional black-and-white line drawing depicting hands handling a small bottle with a cap, demonstrating how to remove the cap by pulling it upward. This likely represents a step in preparing or using the Restasis MultiDose ophthalmic emulsion.*

FDA Label Image

Restasis Multidose 04

Instructional illustration showing a person applying drops from a Restasis MultiDose ophthalmic emulsion bottle onto a surface or applicator, demonstrated by arrows indicating the direction of the liquid flow from the bottle tip.*

FDA Label Image

Restasis Multidose 05

An instructional illustration showing a hand twisting the cap off a Restasis MultiDose ophthalmic emulsion bottle. The image demonstrates the correct method to open the bottle by rotating the cap upward and off before use.*

FDA Label Image

Restasis Multidose 06

An instructional illustration showing hands removing a protective cap from a dropper bottle and preparing to administer eye drops. The image depicts proper handling of an ophthalmic emulsion product, emphasizing hygiene and dosage preparation steps.*

FDA Label Image

Restasis Multidose 07

Chemical structure of cyclosporine, the active ingredient in Restasis MultiDose 0.5 mg/mL ophthalmic emulsion by Allergan, Inc. The diagram shows the molecular configuration of cyclosporine with labeled atom groups and bonds.*

FDA Label Image

Restasis Multidose 08

FDA Label Image

Restasis Multidose 09

Restasis MultiDose ophthalmic emulsion 0.5 mg/mL carton label. The label shows the brand name Restasis MultiDose and indicates the active ingredient cyclosporine. It is labeled for ophthalmic use and provided by Allergan, Inc. The product NDC is 0023-5301.*

FDA Label Image

Restasis Multidose 0a

An instructional illustration showing parts of a Restasis MultiDose (cyclosporine ophthalmic emulsion) bottle. It depicts the shipping cover, colored protective cap, pull tab, bottle tip, and bottle, explaining how to identify each component of the multidose container.*

FDA Label Image

Restasis Multidose 0b

Instructional illustration showing a user holding a bottle of Restasis MultiDose ophthalmic emulsion .5 mg/mL and demonstrating how to remove the cap by pulling it upward. The image focuses on preparing the product for use.*

FDA Label Image

Restasis Multidose 0c

An instructional line drawing illustrating how to use a pull-tab mechanism on a bottle or container. The image shows a hand pulling up on a tab, with an inset demonstrating the tab's removal, likely for opening or accessing the product.*

FDA Label Image

Restasis Multidose 0d

Instructional illustration showing a hand holding a bottle of Restasis MultiDose ophthalmic emulsion and removing or tightening the cap, indicated by upward and downward arrows. The image guides the user on how to open or close the bottle properly before use.*

FDA Label Image

Restasis Multidose 0e

An instructional illustration showing a bottle labeled 4 being squeezed to dispense liquid onto a surface or pad, with two arrows indicating the direction of squeezing and flow.*

FDA Label Image

Restasis Multidose 0f

An instructional illustration showing a hand holding an ophthalmic emulsion bottle, with a cap being placed back on the bottle by pressing downwards. This step is labeled as number 5, indicating part of a multi-step usage or handling procedure for Restasis MultiDose cyclosporine ophthalmic emulsion.*

FDA Label Image

Restasis Multidose 10

An instructional illustration showing hands removing a cap from a dropper bottle, demonstrating how to open the container for use. The image appears related to an ophthalmic emulsion product such as Restasis MultiDose (cyclosporine).*

FDA Label Image

Restasis Multidose 11

Packaging label for Restasis MultiDose cyclosporine ophthalmic emulsion 0.05%, 5.5 mL. The label includes directions for preparing the bottle for first-time use and states the product is sterile, preservative-free, and for topical application in the eye. Labeler Allergan, Inc. and NDC 0023-5301-05 are displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.